Add to ORKGAbstract KCNJ11 gene mutations are related to permanent neonatal diabetes mellitus (PNDM). Glycemic stability minimizes the risk of complications. Sulfonylureas (SU) are the proven best therapeutic option. We report a 18-month follow-up of switching from insulin to SU in a mother and her daughter with PNDM due to KCNJ11 mutation
Mutations in the KCNJ11 gene encoding the adenosine triphosphate (ATP)-sensitive potassium channel (...
Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (P...
Comment on Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes ...
Permanent neonatal diabetes caused by mutations in the KCNJ11 gene may be managed with high-dose sul...
Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes mellitus that occurs in the first 6...
Permanent neonatal diabetes (PNDM) can result from activating heterozygous mutations in KCNJ11 gene,...
Permanent neonatal diabetes (PND) can be caused by mutations in the transcription factors insulin pr...
Background: Permanent neonatal diabetes caused by mutations in the KCNJ11 gene may be managed with h...
Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (P...
Permanent neonatal diabetes mellitus refers to diabetes that occurs before the age of 6 months and p...
Permanent neonatal diabetes mellitus is most commonly caused by mutations in the ATP-sensitive potas...
Activating missense mutations in the gene encoding potassium inwardly rectifying channel, subfamily...
Permanent neonatal diabetes mellitus (PNDM) is a rare condition presenting before six months of age....
BACKGROUND: Neonatal diabetes mellitus (NDM) is a rare but important condition affecting approximate...
A ctivating mutations in the KCJN11gene encoding in the ATP-sensitiveK channel (KATP channel) subun...
Mutations in the KCNJ11 gene encoding the adenosine triphosphate (ATP)-sensitive potassium channel (...
Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (P...
Comment on Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes ...
Permanent neonatal diabetes caused by mutations in the KCNJ11 gene may be managed with high-dose sul...
Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes mellitus that occurs in the first 6...
Permanent neonatal diabetes (PNDM) can result from activating heterozygous mutations in KCNJ11 gene,...
Permanent neonatal diabetes (PND) can be caused by mutations in the transcription factors insulin pr...
Background: Permanent neonatal diabetes caused by mutations in the KCNJ11 gene may be managed with h...
Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (P...
Permanent neonatal diabetes mellitus refers to diabetes that occurs before the age of 6 months and p...
Permanent neonatal diabetes mellitus is most commonly caused by mutations in the ATP-sensitive potas...
Activating missense mutations in the gene encoding potassium inwardly rectifying channel, subfamily...
Permanent neonatal diabetes mellitus (PNDM) is a rare condition presenting before six months of age....
BACKGROUND: Neonatal diabetes mellitus (NDM) is a rare but important condition affecting approximate...
A ctivating mutations in the KCJN11gene encoding in the ATP-sensitiveK channel (KATP channel) subun...
Mutations in the KCNJ11 gene encoding the adenosine triphosphate (ATP)-sensitive potassium channel (...
Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (P...
Comment on Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes ...